Skip to content
Recruiting Phase 1 / Phase 2

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

About this study

This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.

Condition
Autoimmune Diseases, Cardiovascular Disorders, Diabetes Complications, Integumentary Disease, Musculoskeletal Disorders, Neurodegenerative Disorders, Neurologic Disorders, Pulmonary Disorders, Sexual Dysfunction, Urologic Disorders, Viral Illness
Tested
PrimePro™/ PrimeMSK™
Sponsor
Thomas Advanced Medical LLC

Who can join

Age
18 years and older
Sex
All sexes
Healthy volunteers
Accepted

Inclusion 5

  • Minimum age: 18 years
  • Study condition: Autoimmune Diseases, Cardiovascular Disorders, Diabetes Complications, Integumentary Disease, Musculoskeletal Disorders, Neurodegenerative Disorders, Neurologic Disorders, Pulmonary Disorders, Sexual Dysfunction, Urologic Disorders, Viral Illness
  • Age 18 and older
  • Ability to provide informed consent
  • Availability for follow up visits

Exclusion 3

  • Active or recent malignancy (within last 2 years)
  • Pregnancy or breast-feeding
  • Inability to provide informed consent

Where

1 site, 1 recruiting

Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites

Culver City, California, United States

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.